Core Insights - Meiyang Innovation Technology, focused on AI-driven medical robots and smart medical hardware, has completed a Pre-A+ round financing of several hundred million yuan, with funds aimed at accelerating clinical registration, core technology iteration, and market expansion [2][4] Group 1: Company Overview - Since its establishment in 2022, Meiyang has rapidly developed, ranking among the top in AI medical robot financing, highlighting the capital market's recognition of its strategic position in the global medical aesthetics and rehabilitation sectors [4] - The company has created an intelligent closed-loop platform integrating key technologies such as intelligent imaging diagnosis, energy source generator design, and AI deep learning, which has received FDA certification for three types of medical devices [10][11] Group 2: Technology and Innovation - Meiyang's intelligent platform integrates high-precision imaging and multi-modal AI analysis, enabling a leap from micron-level precision intervention to real-time adaptive control, thus redefining non-invasive treatment standards [5][8] - The company focuses on AI and multi-energy source smart hardware, aiming to create a data-driven treatment ecosystem that aligns with international trends and positions itself at a technological high point in global competition [7][8] Group 3: Market Position and Strategy - The company is positioned to benefit from the rapid growth of AI-driven medical hardware, driven by national strategies and the demand for domestic medical device innovation [8][14] - Meiyang's strategy aligns with national policies promoting high-quality development in the medical robot industry, which encourages AI algorithm innovation and personalized treatment systems [14]
美央创新科技完成数亿元Pre-A+轮融资